MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517046441 A) filed by Fertis India Pvt. Ltd., Hyderabad, Telangana, on May 14, for 'novel ophthalmic formulation.'
Inventor(s) include Kanumuru Rahul Raju; Kochumalayil Shaji George; and Suraneni Ravikumar.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "The present invention discloses an ophthalmic formulation/composition comprising cinnamic acids or their derivatives catechins or its derivatives either alone or in combination thereof together with acceptable excipients for treating/clearing/reducing conditions associated with cataract intraocular pressure and glaucoma lenticular degeneration corneal epithelial proliferation and liquefaction and inflammation."
The patent application was internationally filed on Nov. 20, 2023, under International application No.PCT/IN2023/051069.
Disclaimer: Curated by HT Syndication.
